Neuroligin-3: A Novel Exercise-Induced Secreted Factor Enhancing Insulin Sensitivity in Obese Insulin-Resistant Mice
Diabetes · 2026
DOI: 10.2337/db25-0259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2026. Verfasst von Archana Sinha und 11 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Disease Biology Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam, India. Hauptthemen laut MEDLINE: Insulin Resistance, Neuroligins, Obesity, Physical Conditioning, Animal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Indian Council of Medical Research, Department of Biotechnology, Ministry of Science and Technology, India, Wellcome Trust DBT India Alliance.
Abstract (Originalsprache)
The salutary effects of physical exercise in mitigating metabolic disorders, particularly type 2 diabetes, are well recognized. Several studies have demonstrated that endurance training boosts the production of exercise-induced myokines, which are pivotal for interorgan communication enhancing insulin sensitivity. However, several challenges, including an incomplete understanding of underlying molecular mechanisms, hinder their therapeutic application. Here, we have identified a potential exercise-induced mediator, neuroligin-3 (NLGN3), that enhances insulin sensitivity and abrogates inflammation. Mechanistic studies in white adipocytes revealed that NLGN3 interacts with neurexin-3 (NRXN3) to modulate their function and insulin sensitivity, while in macrophages, NLGN3 engages with NRXN1 to attenuate inflammation and promote an anti-inflammatory phenotype. Administration of NLGN3 in high-fat diet (HFD)–fed mice significantly ameliorated obesity-induced visceral adipose tissue dysfunction and insulin insensitivity; however, these attributes are markedly abolished in NRXN1/3-deficient mice. In addition, elevated serum NLGN3 levels following swimming exercise training correlated with improved metabolic outcomes in HFD-fed obese diabetic mice. These findings suggest that NLGN3 may serve as a key mediator of exercise-induced metabolic benefits and highlight the NLGN3-NRXN1/3 pathway as a promising target for managing obesity-induced insulin resistance. Article Highlights This study aimed to identify novel exercise-induced myokines and their role in improving insulin sensitivity and reducing inflammation. We identified neuroligin-3 (NLGN3) as an exercise-induced mediator that enhances insulin sensitivity and alleviates inflammation. Exercise-induced NLGN3 upregulation or recombinant NLGN3 administration improved metabolic function in high-fat diet–fed mice via neurexin-1 and -3 (NRXN1/3), but these benefits were lost upon NRXN1/3 ablation. NLGN3 emerges as a key mediator of exercise-driven metabolic benefits and a promising therapeutic target for obesity-associated insulin resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Metabolic Disease Biology Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam, India.
- Department for Biomedical Engineering, Indian Institute of Technology Ropar, Rupnagar, Punjab, India.
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Punjab, India.
- Genomics and Bioinformatics Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam, India.
ORCID-Profile: Aditya Kumar, Kulbhushan Tikoo, Durba Pal, Suman Dasgupta
Förderung
- Indian Council of Medical Research
- Department of Biotechnology, Ministry of Science and Technology, India
- Wellcome Trust DBT India Alliance
Zitieren
APA
Sinha, A., Patra, D., Mishra, S., Vashisth, A., Sharma, S., Dey, U., Ramprasad, P., Roy, S., Kumar, A., Tikoo, K., Pal, D., & Dasgupta, S. (2026). Neuroligin-3: A Novel Exercise-Induced Secreted Factor Enhancing Insulin Sensitivity in Obese Insulin-Resistant Mice. Diabetes. https://doi.org/10.2337/db25-0259
Vancouver
Sinha A, Patra D, Mishra S, Vashisth A, Sharma S, Dey U, et al. Neuroligin-3: A Novel Exercise-Induced Secreted Factor Enhancing Insulin Sensitivity in Obese Insulin-Resistant Mice. Diabetes. 2026. doi:10.2337/db25-0259
BibTeX
@article{Sinha2026,
author = {Sinha, Archana and Patra, Debarun and Mishra, Subrata and Vashisth, Ankit and Sharma, Shivam and Dey, Upalabdha and Ramprasad, Palla and Roy, Soumyajit and Kumar, Aditya and Tikoo, Kulbhushan and Pal, Durba and Dasgupta, Suman},
title = {Neuroligin-3: A Novel Exercise-Induced Secreted Factor Enhancing Insulin Sensitivity in Obese Insulin-Resistant Mice},
journal = {Diabetes},
year = {2026},
doi = {10.2337/db25-0259}
}
EUVIMED